Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hematology
Studies describe new findings in hematology research
April 19th, 2005
Investigators in Italy, the United States and Netherlands have published new hematology data. Study 1: Interferon-based therapies modify the course of hepatitis C in hemophiliacs. "Hepatitis C is a major cause of morbidity and mortality in hemophiliacs who received clotting factor concentrates before the availability of virus-inactivated factors in the mid-1980s," according to researchers in Italy. "Early studies gave conflicting indications as to the severity of hepatitis C (originally termed non-A non-B hepatitis), as mild, slowly progressive hepatitis was documented in several infants and young adults with hemophilia who were...
Source: Cancer Weekly (2005-04-19)
|
